Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients

Metabolic Brain Disease

Volumn 28, Issue 4, 2013, Pages 619-627

  Fava, Antonietta ^a   Plastino, Massimiliano ^b   Cristiano, Dario ^b   Spanò, Antonio ^b   Cristofaro, Stefano ^b   Opipari, Carlo ^b   Chillà, Antonio ^b   Casalinuovo, Fatima ^b   Colica, Carmen ^c   De Bartolo, Matteo ^d   Pirritano, Domenico ^b   Bosco, Domenico ^b  

^a Fondazione UALSI   (Italy)

^b S Giovanni di Dio Hospital   (Italy)

^c CNR   (Italy)

^d Serv Neurophysiology   (Italy)

Author keywords

Cognitive deficits; Dementia; Diabetes mellitus; Insulin resistance; Pain syndrome

Indexed keywords

C REACTIVE PROTEIN; DULOXETINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREGABALIN; TRIACYLGLYCEROL;

ADULT; AMNESIA; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD PRESSURE MEASUREMENT; BODY MASS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FIBROMYALGIA; GERIATRIC DEPRESSION SCALE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; MEDICAL HISTORY; MEMORY DISORDER; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PSYCHOLOGIC TEST; RISK FACTOR; SELF REPORT; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ANALOG SCALE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

ADULT; AGED; BLOOD GLUCOSE; COGNITION DISORDERS; FEMALE; FIBROMYALGIA; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84887219665     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9421-3     Document Type: Article

References (51)

1. American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation (2007) Consensus statement on the world wide standardization on the HbA1c measurement. Diabetologia 50:2042-2043
2. Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
3. Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA (2002) The role of insulin in human brain glucose metabolism: an 18-fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384-3390
4. Blanchard JG, Duncan PM (1997) Effect of combinations of insulin, glucose and scopolamine on radial arm maze performance. Pharmacol Biochem Behav 58(1):209-214
5. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 47:1643-1649
6. Bosco D, Costa R, Plastino M, Branca D, Cotronei P, Santacroce N, Siniscalchi A, Consoli D, Ceccotti C, Mungari P, Fava A (2009) Glucose metabolism in the idiopathic blepharoptosis: utility of the oral glucose tolerance test (OGTT) and of the insulin resistance index. J Neurol Sci 284:24-28
7. Bosco D, Fava A, Plastino M, Montalcini T, Pujia A (2011) Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med 15(9):1807-1821
8. Cleeman JI (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 285(19):2486-2497
9. Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385-396
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care 26:S4-S20
11. Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
12. Grace GM, Nielson WR, Hopkins M, Berg MA (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21:477-487
13. Greisen J, Juhl CB, Grofte T, Vilstrup H, Jensen TS, Schmitz O (2001) Acute pain induces insulin resistance in humans. Anesthesiology 95:578-584
14. Jonides J (1995) Working memory and thinking. In: Smith EE, Osherson DN (eds) An invitation to cognitive science: thinking, vol 3. MIT Press, Cambridge, pp 215-265
15. Landro NI, Stiles TC, Sletvold H (1997) Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42:297-306
16. Landsberg L (1999) Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome. Ann NY Acad Sci 892:84-90
17. Laws A, Reaven GM (1993) Insulin resistance and risk factors for coronary heart disease. Bailliere's Clin Endocrinol Metabol 7:1063-1078
18. Leavitt F, Katz RS (2006) Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 33:127-132
19. Lee ZS, Critchley JA, Tomlinnson B, Young RP, Thomas GN, Cockram CS, Chan TY, Chan JC (2001) Urinary epinephrine and norepinephrine 3interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 50:135-143
20. Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York, pp 333-335
21. Lipman RS (1982) Differentiating anxiety and depression in anxiety disorders: use of rating scale. Psychormacol Bull 18:69-77
22. Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56:87-93
23. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer's disease. Neurology 63:1187-1192
24. Martinez-Lavin M, Hermosillo AG (2000) Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 29:197-199
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Meenan RF, Mason JH, Anderson J, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded arthritis impact measurement scale health status questionnaire. Arthritis Rheum 35:1-10
27. Melzack R (1987) The short-form McGill pain questionnaire. Pain 30:191-197
28. Mersekey H, Bog-Duk N (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Monograph fort he task force of taxonomy, 2nd edn. International Association for the Study of Pain, Seattle, pp 45-47
29. Okifuji A, Bradshaw DH, Olson C (2009) Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Reumatol 28:475-478
30. Ott A, Stolk RP, Van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the Rotterdarm Study. Neurology 53:1937-1942
31. Park DC, Smith AD, Lautenschlager G, Earles JL, Frieske D, Zwahr M, Gaines CL (1996) Mediators of long-term memory performance across the life span. Psychol Aging 22:137-142
32. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677-684
33. Pi-Sunyer FX (2000) Obesity: criteria and classification. Proc Nutr Soc 59:505-509
34. Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D (2010) Effects of insulin therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288:112-116
35. Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue and pain. J Psychosom Res 55:321-329
36. Svetvold H, Stiles TC, Landro NI (1995) Information processing in primary fibromyalgia, major depression and healthy controls. J Rheumatol 22:137-142
37. Talbot K, Wang H-Y, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation and cognitive decline. J Clin Investig 122:1316-1338
38. Tewes U (1991) Handbuch and Testanweisungen fur den Hamburg-Wechsler Intelligenztest fur Erwachesene Revision
39. Tsigos C, Chrousos GP (2004) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 57:451-458
40. Uchida I, Asoh T, Shirasaka C, Tsuji H (1988) Effect of epidural analgesia on postoperative insulin resistance as evaluated by insulin clamp technique. Br J Surg 75:557-562
41. Wallitt B, Roebuck-Spencer T, Bleiberg J, Forster G, Weinstein A (2008) Automated neuropsychiatric measurements of information processing in fibromyalgia. Reumathol Int 28:561-566
42. Watson GS, Bernhardt T, Reger MA, Chorleton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frolich L, Craft S (2006) Insulin effects on CSF norepinephrine and cognition in Alzheimer disease. Neurobiol Aging 27:38-41
43. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172
44. Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151-156
45. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600-610
46. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kungshol men project: a 6-year follow-up study. Neurology 63:1181-1186
47. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237-2242
48. Yanmaz MN, Mert M, Korkmaz M (2011) The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int 8:1018-1022
49. Yesavage JA, Brink TL (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37-49
50. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J Rheumatol 19:95-97
51. Ziemus B, Baumann O, Luerding R, Schlosser R, Schuierer G, Bogdahn U, Greenlee MW (2007) Impaired working-memory after cerebellar infarcts paralleled by changes in BOLD signal of a cortico-cerebellar circuit. Neuropsychologia 45:2016-2024